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Abstract 
Background: Lactic acid bacteria (LAB) are promising vehicles for delivery of a variety of medicinal compounds, 
including antigens and cytokines. It has also been established that LAB are able to deliver cDNA to host cells. To 
increase the efficiency of LAB‑driven DNA delivery we have constructed Lactobacillus plantarum strains targeting DEC‑
205, which is a receptor located at the surface of dendritic cells (DCs). The purpose was to increase uptake of bacterial 
cells, which could lead to improved cDNA delivery to immune cells.
Results: Anti‑DEC‑205 antibody (aDec) was displayed at the surface of L. plantarum using three different anchoring 
strategies: (1) covalent anchoring of aDec to the cell membrane (Lipobox domain, Lip); (2) covalent anchoring to the 
cell wall (LPXTG domain, CWA); (3) non‑covalent anchoring to the cell wall (LysM domain, LysM). aDec was success‑
fully expressed in all three strains, but surface location of the antibody could only be demonstrated for the two strains 
with cell wall anchors (CWA and LysM). Co‑incubation of the engineered strains and DCs showed increased uptake 
when anchoring aDec using the CWA or LysM anchors. In a competition assay, free anti‑DEC abolished the increased 
uptake, showing that the internalization is due to specific interactions between the DEC‑205 receptor and aDec. 
To test plasmid transfer, a plasmid for expression of GFP under control of an eukaryotic promoter was transformed 
into the aDec expressing strains and GFP expression in DCs was indeed increased when using the strains producing 
cell‑wall anchored aDec. Plasmid transfer to DCs in the gastro intestinal tract was also detected using a mouse model. 
Surprisingly, in mice the highest expression of GFP was observed for the strain in which aDec was coupled to the cell 
membrane.
Conclusion: The results show that surface expression of aDec leads to increased internalization of L. plantarum and 
plasmid transfer in DCs and that efficiency depends on the type of anchor used. Interestingly, in vitro data indicates 
that cell wall anchoring is more effective, whereas in vivo data seem to indicate that anchoring to the cell membrane 
is preferable. It is likely that the more embedded localization of aDec in the latter case is favorable when cells are 
exposed to the harsh conditions of the gastro‑intestinal tract.
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Background
DNA vaccination relies on the injection of a plas-
mid containing cDNA under control of an eukaryotic 
promoter into host cells. It has been shown that DNA 
vaccination is able to elicit immune responses compara-
ble to the responses generated by attenuated pathogens 
[1]. DNA vaccines can be administered by intramus-
cular injection of DNA, but this strategy needs trained 
staff and equipment, and may in some cases suffer from 
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DNA instability [2]. Mucosal delivery of the vaccines is 
of interest because it can elicit both local and systemic 
immunization. Because DNA is very sensitive to the 
physico-chemical conditions in the gut, the use of DNA 
vaccination at the mucosal level implies the development 
of vectors able to protect the DNA. Alternatives include 
encapsulation of the cDNA in nanoparticles of polysac-
charides or in liposomes, as well as the use of bacterial 
vectors [3–5].
Lactic acid bacteria (LAB) including Lactobacillus, Lac-
tococcus, Streptococcus or Enterococcus are Gram positive 
bacteria. LAB are present in a wide range of ecological 
niches such as plant material and the gastro intestinal 
tract (GIT) and they have been used for thousands years 
in fermented food products. LAB have been given the 
GRAS (generally recognized as safe) status by the World 
Health Organization and several LAB strains have probi-
otic properties. Probiotic effects of LAB have been shown 
to be beneficial in relation to lactose intolerance [6], diar-
rhea [7], allergy [8, 9], inflammatory bowel disease (IBD) 
[10] and cancer [11]. Notably, the beneficial effects of 
LAB include immunomodulatory effects and an adju-
vant-type of action [12]. One of the LAB for which such 
effects have been studied in most detail is Lactobacillus 
plantarum [12] [8] [13]. Importantly, LAB resist low pH 
and the harsh conditions in the GIT, making them a vec-
tor of choice for oral administration.
The possibility of LAB delivering cDNA to host cells 
has proven its efficiency in several applications. The first 
demonstration concerned a Lactococcus lactis strain car-
rying cDNA encoding β-lactoglobulin (BLG), one of the 
major allergens in milk [14, 15]. Recently, it was shown 
that L. lactis carrying cDNA encoding IL-10 under con-
trol of the eukaryotic cytomegalovirus (CMV) promoter 
has protective effects in a mouse model of trinitroben-
zene sulfonic (TNBS) acid-induced colitis [16]. Delivery 
of a DNA vaccine by L. acidophilus had a positive effect 
in protecting mice from foot and mouth disease [17].
Enhancing interactions between host cells and LAB 
may be one way to increase the transfer efficiency of 
cDNA-based vaccines, and therefore, several stud-
ies aimed at targeting specific cellular populations have 
been performed. For example, fibronectin binding pro-
tein A (FnBPA) from Staphylococcus aureus and mutated 
internalin A (InlA) from Listeria monocytogenes have 
been successfully expressed at the surface of L. lactis [18, 
19]. These two proteins are responsible for binding of S. 
aureus and L. monocytogenes, respectively, to epithelial 
cells by interacting with specific receptors [20, 21]. Bind-
ing is the first step towards internalization and it was 
indeed shown that transfer of a plasmid expressing either 
GFP or BLG was enhanced when LAB expressed FnBPA 
or mutated InlA [18, 19].
Dendritic cells (DCs) are antigen presenting cells and 
thus major players in the immune response. They are 
present in tissue mucosa, under the epithelial barrier 
of the gut, and they can extend dendrites through tight 
junctions to sample antigens in the lumen [22]. DCs are 
an important link between the exterior and the immune 
system. They have numerous different pattern recogni-
tion receptors (PRRs) and when they encounter a poten-
tial pathogen, they switch to an activated state [23]. Once 
activated, they migrate to lymph nodes where they stimu-
late T cells proliferation and differentiation.
One of the PRRs present in DCs is DEC-205 (or 
CD-205) which is a C-type lectin receptor involved in 
recognition of ligands expressed during apoptosis and 
necrosis of cells [24], in recognition of CpG oligonucleo-
tides [25] and in antigen processing [26]. This receptor 
has been a target in several vaccine improvement stud-
ies [27]. For example, tumor associated antigen HER2/
neu has been fused to a single chain Fv fragment (ScFv) 
targeting DEC-205. Administration of the fusion pro-
tein elicited a higher cellular and humoral response and 
had a stronger protective effect against tumor forma-
tion, compared to the antigen alone [28]. DEC-205 is also 
a target to induce tolerance to substances. For example, 
Bruder et  al. [29] showed that fusing a tolerogenic vac-
cine against type 1 diabetes to an anti-DEC-205 antibody 
protected mice from developing this autoimmune dis-
ease. These effects are likely due to the fact that when an 
antigen is endocytosed via DEC-205, it is presented to 
the immune system through both MHC class I and MHC 
class II molecules, thus to both CD4+ and CD8+ T cells 
[30].
In the present study, we investigated the potential of 
targeting DEC-205 as a tool to enhance interactions 
between LAB and DCs and thus plasmid DNA delivery. 
We have constructed strains of L. plantarum expressing 
a recombinant ScFv against murine DEC-205 (aDec) at 
their surface, using three different surface anchors. We 
show that surface localization of aDec in L. plantarum 
has the potential to increase internalization of the bac-
terium and plasmid transfer both in cell culture and in 
mice and that this potential depends on the type of sur-
face anchor.
Results
Construction of recombinant Lactobacillus plantarum 
strains producing the anti‑DEC‑205 ScFv
A DNA fragment encoding the anti-mouse Dec205 ScFv 
(aDec) preceded by a HA-tag for immune detection was 
cloned into plasmids previously developed for produc-
tion and surface localization of proteins in L. plantarum 
(32, 26) using three different types of anchors as outlined 
in Figure  1a, b. The anchors are: a Lipobox membrane 
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anchor for covalent coupling of aDec to a membrane 
component, a cell wall anchor based on sortase-catalyzed 
covalent coupling to the peptidoglycan and a cell wall 
anchor based on non-covalent interactions between a 
LysM domain and the cell wall. The three resulting plas-
mids, pLip-aDec, pCWA-aDec and pLysM-aDec (Fig-
ure 1b) were transformed into L. plantarum. In addition, 
we used Lp-WT, containing a control plasmid (pEV) [31] 
that does not encode for the anchors or aDec, as a nega-
tive control. The growth rate of strains producing aDec 
was substantially lower compared to control strain (Fig-
ure 1c), in particular for the strain harboring the lipopro-
tein anchor. Still, all strains showed reasonable growth 
and bacteria harvested 2  h after induction, where all 
Figure 1 Characterization of aDec‑expressing L. plantarum strains. a Schematic representation of the three anchors used. b Expression cassettes in 
which the gene fragment encoding the desired protein is translationally fused to the inducible PsppA promoter [47]. The cassette was PCR‑generated 
using the primers listed in Table 2 and inserted into previously described anchoring vectors [31, 36] digested with the restriction enzymes indicated 
in the Figure, as summarized in Table 3. All constructs include a N‑terminal signal sequence (SP) for secretion and a HA‑tag for immune detection. 
Three different anchoring domains were used, as described in the main text. Note that in the CWA construct, the anchoring domain is located C‑ter‑
minally, meaning that the HA‑tag will protrude from the cells after secretion and subsequent anchoring. c Growth curves for Lp‑WT (control strain) 
and aDec‑expressing strains; protein production was induced by addition of peptide pheromone at OD600 ~0.3. d Western blot analysis of cell‑free 
protein extracts from aDec‑expressing strains harvested 2 h after induction, using a mouse anti‑HA primary antibody and a HRP‑conjugated goat 
anti‑mouse secondary antibody. e Flow cytometry analysis of the presence of aDec at the surface of Lp‑WT (in black) compared to Lp‑Lip‑aDec, Lp‑
CWA‑aDec or Lp‑LysM‑aDec (all in red).
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transformants have a similar OD600 (Figure 1c) and simi-
lar cell counts, were used for further studies.
Western blot analysis of protein extracts of induced 
strains using anti-HA antibodies revealed the presence 
of HA tagged proteins with correct molecular size in all 
three aDec-producing strains (Figure 1d). To check sur-
face localization we labeled the strains with a fluorescent 
anti-HA antibody and tested antibody binding by flow 
cytometry. Lp-CWA-aDec and Lp-LysM-aDec, but not 
Lp-Lip-aDec showed higher fluorescence than Lp-WT 
(Figure 1e). Taken together these results show that aDec 
is expressed in all three aDec-producing strains. How-
ever, aDec is only detectable at the surface in the two 
strains where aDec is fused to the cell wall anchors.
Internalization of aDec‑displaying L. plantarum 
by dendritic cells
To test interactions of the recombinant strains with DCs 
derived from humans (hDCs) or mice bone marrow den-
dritic cells (BMDCs), we first performed internalization 
assays. Figure  2 shows that the number of internalized 
bacteria was significantly higher after co-incubation 
with Lp-CWA-aDec and Lp-LysM-aDec compared to 
Lp-WT or Lp-Lip-aDec. To investigate the specificity of 
the interactions between the displayed anti-mouse ScFv 
and human DCs, a competition experiment was carried 
in which the hDCs were pre-treated with a monoclo-
nal antibody against human DEC-205. The results (Fig-
ure 2a) clearly show that increased internalization caused 
by surface display of aDec is abolished in the presence of 
the competing free antibody, which proofs that increased 
internalization is due to a specific interaction between the 
recombinant strains and DEC-205 on the DCs.
Effect of aDec expression on plasmid transfer to dendritic 
cells
To investigate the potential of the recombinant strains for 
plasmid transfer we transformed the strains with an addi-
tional plasmid, pValac-GFP [32] for expression of GFP 
cDNA under the control of the eukaryotic CMV promoter. 
We thus obtained Lp-WT/pValac-GFP, Lp-Lip-aDec/
pValac-GFP, Lp-CWA-aDec/pValac-GFP and Lp-LysM-
aDec/pValac-GFP (Table 1). Growth of the pValac-GFP con-
taining double transformants was similar to growth of the 
corresponding single transformants depicted in Figure  1c. 
Figure 3a shows that the number of hDCs expressing GFP 
was significantly higher after co-incubation with Lp-CWA-
aDec/pValac-GFP or Lp-LysM-aDec/pValac-GFP compared 
to Lp-WT/pValac-GFP or Lp-Lip-aDec/pValac-GFP. Simi-
lar results, although with lower significance, were obtained 
with BMDCs (Figure  3b). Competition experiments with 
the free anti DEC-205 antibody showed that increased plas-
mid transfer is due to a specific interaction between the 
recombinant strains and DEC-205 on the DCs.
Plasmid delivery from bacteria to dendritic cells in vivo
To investigate the potential of the recombinant strains 
for plasmid transfer in  vivo the recombinant strains 
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Figure 2 Effect of surface expression of aDec on internalization of L. plantarum by DCs. a Monocyte derived hDCs were co‑incubated with Lp‑WT, 
Lp‑Lip‑aDec, Lp‑CWA‑aDec or Lp‑LysM‑aDec with or without addition of a free anti human DEC205 antibody. After incubation, the hDCs were 
washed and non‑internalized bacteria were killed by treatment with gentamicin. The numbers of internalized bacteria were counted as CFU. Same 
amount of DCs was used in each experiment. b BMDCs were co‑incubated with Lp‑WT, Lp‑Lip‑aDec, Lp‑CWA‑aDec or Lp‑LysM‑aDec. After incuba‑
tion, the BMDCs were washed and non‑internalized bacteria were killed by treatment with gentamicin. The numbers of internalized bacteria were 
counted as CFU. Each point represents independent wells and results are presented as mean ± SEM. The results presented are from one experiment 
representative of three performed independently. Statistically significant differences are indicated as follows: *p < 0.05; **p < 0.01; ***p < 0.001.
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containing pValacGFP were administered to mice. After 
4 days of oral administration of the four different strains, 
mice were euthanized and DCs were isolated from 
the intestine and the colon. Quantification of the frac-
tion of fluorescent DCs by flow cytometry showed that, 
compared to mice fed with control strain, this fraction 
was higher in both the intestine (Figure 4a) and the colon 
(Figure 4b) for mice fed with Lp-Lip-Dec/pValac-GFP. A 
similar trend, but not significant, was observed for mice 
fed with Lp-LysM-aDec/pValac-GFP. Thus, expression of 
Table 1 Bacterial strains and plasmids used in this study
Designation Strains Characteristic References
Lb. Plantarum WCFS1 Host strain [34]
E. coli TOP10 Host strain Invitrogen
Lp‑WT WCFS1 with pEV This study
Lp‑WT/pValac‑GFP WCFS1 with pEV and pValac‑GFP This study
aDec strains Lp‑Lip‑aDec WCFS1 with pLip‑aDec This study
Lp‑CWA‑aDec WCFS1 with pCWA‑aDec This study
Lp‑LysM‑aDec WCFS1 with pLysM‑aDec This study
Lp‑Lip‑aDec/pValac‑GFP WCFS1 with pLip‑aDec and pValac‑GFP This study
Lp‑CWA‑aDec/pValac‑GFP WCFS1 with pCWA‑aDec and pValac‑GFP This study
Lp‑LysM‑aDec/pValac‑GFP WCFS1 with pLysM‑aDec and pValac‑GFP This study
Designation Plasmids Characteristic References
pEV Control plasmid [31]
aDec plasmids pLip‑aDec Plasmid expressing aDec with lipoanchor This study
pCWA‑aDec Plasmid expressing aDec with LPXTG anchor This study
pLysM‑aDec Plasmid expressing aDec with LysM anchor This study
pValac‑GFP Plasmid expressing GFP under CMV promoter [32]
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Figure 3 Effect of surface expression of aDec on plasmid delivery into DCs. a Monocyte derived hDCs were co‑incubated with Lp‑WT/pValac‑GFP, 
Lp‑Lip‑aDec/pValac‑GFP, Lp‑CWA‑aDec/pValac‑GFP or Lp‑LysM‑aDec/pValac‑GFP with or without addition of a free anti‑human DEC205 antibody. 
After incubation the percentage of green fluorescent DCs was determined by flow cytometry. b BMDCs were co‑incubated with Lp‑WT/pValac‑GFP, 
Lp‑Lip‑aDec/pValac‑GFP, Lp‑CWA‑aDec/pValac‑GFP or Lp‑LysM‑aDec/pValac‑GFP. After incubation, the percentage of fluorescent DCs was deter‑
mined by flow cytometry. Each point represents independent wells and the results are presented as mean ± SEM. The results presented are from 
one experiment representative of three performed independently. Statistically significant differences are indicated as follows: *p < 0.05; **p < 0.01; 
***p < 0.001.
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aDec at the membrane of L. plantarum enhances plasmid 
transfer in  vivo, but the preferred anchor (Lip) differs 
from the anchors that were most efficient in vitro (CWA 
and LysM).
Discussion
In the last decade promising results have been reported 
concerning the potential of LAB for drug delivery [33]. 
One of the most thoroughly studied LAB is L. plantarum 
whose genome was one of the first bacterial genomes to 
be sequenced [34]. Some L. plantarum strains have been 
described as probiotics [12] and the persistence of these 
species in the GIT is a main advantage for drug deliv-
ery. Several previous studies have shown that L. plan-
tarum can be modified to express a variety of medicinally 
important proteins and that surface anchoring can be 
achieved in various manners [35, 36]. Importantly, a 
previous study on anchoring invasin on the surface of L. 
plantarum showed that the functionality of the invasin-
expressing strains depended on the type of anchor used 
[31]. Here, we have used these previously described 
anchors to explore a strategy for targeting DCs, with the 
ultimate goal of using this novel trait to develop more 
efficient LAB-based DNA vaccines.
Three surface-anchoring strategies were used to display 
aDec, an ScFv fragment binding to DEC-205, a C-type 
lectin receptor of the DCs membrane (Figure 1). Western 
blotting showed that the antibody fragment was indeed 
produced in all three corresponding strains, but in sub-
sequent flow cytometry analyses it was only detected at 
the surface in two of these. The lack of detection of aDec 
at surface of the Lp-Lip-aDec strain, despite the protein 
being highly expressed (Figure 1d), is most likely caused 
by the protein being embedded in the cell wall. The local-
ization of the HA-tag at the very N-terminus of the pro-
tein, i.e. directly after the lipo-anchor, may preclude its 
detection with the anti-HA antibody.
In order to test the effects of our surface display of an 
anti-DEC205 ScFv on bacteria-DCs interactions, we used 
two sources of DCs, murine BMDCs and human DCs 
derived form monocytes which are known to express 
DEC205 at their surface [37] [38]. Internalization assays 
showed that surface display of aDec indeed increases 
internalization by human DCs and, to a lesser extent, 
murine BMDCs. Internalization by DCs was significantly 
higher for Lp-CWA-aDec and Lp-LysM-aDec strains 
compared to Lp-WT and the lipoprotein construct Lp-
Lip-aDec. The lack of internalization of Lp-Lip-aDec 
could be due to limited accessibility of aDec, as alluded 
to above. Importantly, competition assays with free anti-
bodies confirmed that increased internalization indeed is 
due to specific interactions of the recombinant lactoba-
cilli with DEC-205. This shows that L. plantarum is able 
to produce at its surface a fully functional recombinant 
antibody, which leads to increased internalization of the 
recombinant bacteria by the DCs.
One of the aims of the present study was to enhance 
the internalization efficiency of bacteria in DCs and, in 
addition, to optimize transfer of a functional plasmid 
into the DCs. To test this, we transformed the three aDec 
producing strains and the control strain with pValac-
GFP, a plasmid previously described containing an 
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Figure 4 Effect of surface expression of aDec on plasmid transfer to mouse DCs in vivo. Mice were orally administrated with Lp‑WT/pValac‑GFP, Lp‑
Lip‑aDec/pValac‑GFP, Lp‑CWA‑aDec/pValac‑GFP or Lp‑LysM‑aDec/pValac‑GFP during 4 days. At day 4 mice were sacrificed and DCs were extracted 
from the small intestine (a) or the colon (b). The percentage of DCs expressing GFP was measured by flow cytometry. Each point represents 
independent mice and the results are presented as mean ± SEM. Statistically significant differences are indicated as follows: *p < 0.05; **p < 0.01; 
***p < 0.001.
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expression cassette with GFP cDNA under the control of 
an eukaryotic promoter [15]. DCs co-incubated with Lp-
CWA-aDec/pValac-GFP or Lp-LysM-aDec/pValac-GFP 
showed significantly higher fractions of GFP expressing 
cells compared to DCs co-incubated with Lp-Lip-aDec/
pValac-GFP or Lp-WT-aDec/pValac-GFP. Thus, those 
strains in which the highest levels of surface-located 
aDec were detected also showed the highest levels of 
internalization. We have previously observed a correla-
tion between the extent of internalization of bacteria and 
the extent of plasmid transfer [39]. For example expres-
sion of FnBPa or InlA at the surface of L. lactis increased 
internalization in Caco-2 cells and enhanced plasmid 
transfer both in vitro and in vivo [40–42].
To test the uptake and transfer of the GFP encoding 
plasmid in  vivo, mice were orally administrated with 
relevant strains and plasmid transfer was monitored 
by GFP expression in DCs extracted from the GIT. Sur-
prisingly, we observed significantly higher expression of 
GFP in DCs from mice administrated with Lp-Lip-aDec/
pValac-GFP compared to other strains. The same trend 
was observed in mice fed with Lp-LysM-aDec/pValac-
GFP, but in this case the increase was not significant. 
Thus, the strain that showed good protein expression but 
that seemed least efficient in terms of surface display and 
in vitro internalization and plasmid transfer gave the best 
in vivo results. Another factor potentially playing a role 
could be that the (harsh) conditions in the gut change the 
cell wall of the bacteria, which somehow could promote 
exposure of cell-wall embedded Lip-aDec.
Several studies, mainly using nanoparticles, have shown 
the efficiency of targeting a vaccine to DCs using aDec. 
For example, liposomes or bacteriophages displaying 
anti-DEC-205 and producing the OVA antigen induced 
protective effects against highly metastatic murine mel-
anoma (B16-OVA) in mice [43, 44]. Importantly, use of 
DEC-205 targeting nanoparticles was shown to be more 
efficient than administrating nanoparticles without tar-
geting molecules [45]. The present study adds LAB as a 
possible DEC-205 targeting delivery vehicle. Existing 
data show the possibility of replace the model GFP gene 
used here by other medically important genes.
Conclusions
We show that L. plantarum is able to produce and sur-
face display a fully functional recombinant antibody, 
aDec, and thus target the DEC-205 receptor, which 
results in increased internalization of the bacteria. The 
results further show that the functionality of the aDec-
expressing strains depends on the type of anchor used. 
Expression of surface-located aDec increases plasmid 
transfer from bacteria to DCs in  vitro and in the GIT. 
The data indicate that to achieve efficient internalization 
in the GIT, a more embedded and protected localization 
of aDec is required.
Methods
Bacterial strains and induction
The bacterial strains and plasmids used in this study are 
listed in Table 1. Escherichia coli TOP10 cells (Invitrogen) 
were grown in brain heart infusion (BHI) broth (Oxoid) 
at 37°C with shaking. L. plantarum cells were grown 
statically in MRS broth (Oxoid) at 37°C. Solid media 
were prepared by adding 1.5% (w/v) agar to the broth. 
Plasmid constructs were first established in E. coli cells 
and subsequently after transformed into electrocompe-
tent L. plantarum cells as described previously [46]. The 
antibiotic concentrations used were 5 and 200 µg/mL of 
erythromycin for L. plantarum and E. coli, respectively 
and 10 µg/mL of chloramphenicol. Induction of protein 
expression was done by adding the inducing peptide 
pheromone (SppIP) to a final concentration of 25 ng/mL 
at OD600 = 0.3, according to Sørvig et al. [47].
DNA manipulations and plasmid construction
DNA manipulations were performed essentially as pre-
viously described [48]. The primers used in this study 
were purchased from Operon Biotechnologies and are 
listed in Table 2. We used the sequence of a single chain 
anti mouse DEC-205 Fv fragment [49] to design a syn-
thetic gene, codon optimized for L. plantarum expres-
sion, comprising the Fv fragment with an N-terminal 
HA (hemagglutinin) tag (YPYDVPDYA), which was pro-
duced by Geneart (Lifetech). The plasmid containing the 
synthetic gene was then used as template in subsequent 
PCR reactions using hot start KOD polymerase (Toyobo). 
Amplified PCR fragments were separated on 1% aga-
rose gels and purified using the NucleoSpin extract II kit 
(Macherey–Nagel). After purification the PCR fragments 
were cloned into restriction-digested plasmids contain-
ing various secretion and anchoring signals [31, 36] using 
the In-Fusion HD cloning kit (Clontech Laboratories), 
following the manufacturer’s instructions. Vectors, prim-
ers and restriction enzymes used in cloning are summa-
rized in Table  3 and essential aspects of the constructs 
Table 2 List of PCR primers used in this study
Primer 
name
Sequence
LipaDecFW GATTGCGGCGGTCGACTATCCATATGATGTTCCAGATTATGC
LipaDecBW CCGGGGTACCGAATTCTTACGATATCCCTGATGAAACTGTAAC
CwaaDecFW TGCTTCATCAGTCGACTATCCATATGATGTTCCAGATTATGC
CwaaDecBW GTTCAGTGACACGCGTCGATATCCCTGATGAAACTGT
LysMdecFW TTGGGCCCTTGTCGACTATCCATATGATGTTCCAGATTATGC
LysMdecBW CCGGGGTACCGAATTCTTACGATATCCCTGATGAAACTGTAAC
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are displayed in Figure  1b. Plasmid DNA was purified 
from E. coli using the NucleoSpin plasmid kit (Mach-
erey–Nagel GmbH & Co). Competent L. plantarum were 
transformed by electroporation according to a previously 
described method [46]. The DNA sequences of all PCR 
amplicons were verified by sequence analysis.
Protein extraction and western blot
The bacteria were harvested 2  h after induction and 
washed twice with ice-cold Tris-buffered sucrose (pH 7.0, 
10  mM MgCl2, 250  mM sucrose). After centrifugation, 
the bacteria were disrupted by glass beads (106 micron, 
Sigma) using a FastPrep®-24 instrument (MP Biomedi-
cals) to obtain protein extracts. After cell disruption and 
centrifugation, cell-free supernatants were mixed with 
SDS-PAGE sample buffer. After boiling the samples for 
7 min, they were applied to 10% Stain-Free gels (Biorad), 
followed by electrophoresis with subsequent immunob-
lotting using the iBlot system (Thermo Fisher Scientific) 
according to the instructions of the manufacturer. Pro-
tein detection was performed with the SNAP i.d. System 
(Millipore), using a murine anti-HA antibody (Sigma) 
and a horseradish peroxidase (HRP)-conjugated goat 
anti-mouse antibody (BioRad). Proteins were visualized 
using the SuperSignal West Pico chemiluminescent sub-
strate (Pierce).
Detection of aDec at the surface of L. plantarum
Approximately 5  ×  108 bacterial cells determined by 
colony forming unit were harvested by centrifugation 
and washed three times with cold PBS. The bacteria were 
resuspended in 300 µL PBS containing 1% bovine serum 
albumin (PBS-B) and 10  µL of monoclonal Anti-HA–
FITC antibody (1  mg/mL). After incubation at 4°C for 
30–60 min, the bacteria were centrifuged at 7,000×g for 
2 min at 4°C and washed three times with 500 µL ice-cold 
PBS. The bacteria were subsequently fixed in 100  µL of 
2% paraformaldehyde (VWR) in water for 30–60 min at 
4°C. Bacteria were collected by centrifugation at 7,000×g 
for 2  min, washed three times with 500  µL PBS-B and 
resuspended in PBS. Fluorescent staining of resus-
pended bacteria was analyzed by flow cytometry using 
a MACSQuant analyzer (Miltenyi Biotec GmbH, Ber-
gisch Gladbach, Germany), following the manufacturer’s 
instructions.
Preparation of human dendritic cells (hDCs) and FACS 
analysis
Human peripheral leukocytes were prepared from blood 
provided by healthy volunteers according to institutional 
guidelines (Østfold Hospital Trust). Blood of four differ-
ent donors was used. Blood was mixed with an equivalent 
volume of sterile PBS and half a volume of Lymphoprep 
(Stemcell technologies), and centrifuged for 25  min at 
1,500×g. Lymphocyte obtained with the gradient were 
extracted and washed three times with PBS with 10 min 
of centrifugation at 1,000×g after each step. The last cen-
trifuge was performed at 700×g to withdraw plates. The 
purified peripheral leukocytes were stored in 50% RPMI 
1640 medium (PAA Laboratories) and 50% dimethylsul-
foxide (Sigma) in liquid nitrogen.
Human peripheral leukocytes were sorted using a Macs 
separator and Macs CD14 plus microbeads (Miltenyi 
Biotec) according to the supplier’s instructions. CD14+ 
cells were grown for 6 days in RPMI 1640 medium (PAA 
Laboratories GmbH) supplemented with 1  mM sodium 
pyruvate, 50  mM thioglycerol, 25  µg/mL gentamicin 
(Garamycin), 10% (m/v) fetal calf serum (Gibco Life 
Technologies), 25 µg/mL of IL-4 (R&D) and 50 ng/mL of 
human granulocyte macrophage colony-stimulating fac-
tor (GMCSF) (Abcam). Cells were grown in a humidified 
incubator at 37°C and 5% CO2 for 6 days.
Number and size of hDCs cells were evaluated by incu-
bation with mouse anti-human CD86 Alexa Fluor®700-
conjugated antibody (BD Biosciences) for 1  h at room 
temperature protected from light. After incubation cells 
were washed twice with PBS and analyzed by flow cytome-
try using a MACSQuant analyzer (Miltenyi Biotec GmbH), 
following the manufacturer’s instructions. Proportion 
above 90% of CD86 positive cells were routinely obtained.
Preparation of bone marrow dendritic cells (BMDCs) 
and FACS analysis
Bone marrow cells from 6 weeks Balb/c female mice (Jan-
vier) were extracted from leg bones with a 25G  ×  5/8 
needle (Terumo). Red blood cells were eliminated by 
treatment with red blood cell lysis buffer (Sigma) at 
room temperature, following the manufacturer’s pro-
tocol. After centrifugation, the cells were washed three 
times with RPMI1640 (PAA Laboratories). The cells were 
then resuspended and grown for 10 days in RPMI 1640 
Table 3 Method for plasmid construction
Plasmid name Original plasmid References Restriction sites Primer used for aDEC amplification
pLip‑aDec pLp_1452Inv [31] SalI, EcoRI LipaDecFW, LipaDecBW
pCWA‑aDec pLp_0373sOFAcwa2 [36] SalI, MluI CwaaDecFW, CwaaDecBW
pLysM‑aDec pLp_3014Inv [31] SalI, EcoRI LysMdecFW, LysMdecBW
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medium containing 1  mM sodium pyruvate, 50  mM 
thioglycerol, 25 µg/mL penicillin streptomycin (Garamy-
cin), 10% fetal calf serum (Gibco Life Technologies), and 
50  ng/mL mouse GMCSF (Biolegend), in a humidified 
incubator at 37°C with 5% CO2.
Number and size of BMDCs cells were evaluated by 
incubation with alexa-fluor-488 anti-CD86 (Biolegend) 
and R-PE conjugated Monoclonal antibody specific to 
Mouse CD11c (invitrogen). Marking was analyzed by 
flow cytometry using a MACSQuant analyzer (Miltenyi 
Biotec), following the manufacturer’s instructions. Pro-
portion above 90% of CD86 and CD11c positive cells 
were routinely obtained.
Internalization assay
1  ×  108 bacteria determined by colony forming unit 
suspended in 100  µL 1  M Tris buffer, pH 8.5, were co-
incubated with 1 × 105 BMDCs or hDCs (multiplicity of 
infection =  200) for 2 h in 500 µL RPMI 1640 medium 
without antibiotics, in 5% CO2 at 37°C. After incuba-
tion, the cells were washed three times with 1  mL PBS 
and incubated in 500 µL RPMI 1640 containing 150 µg/
mL of gentamicin for 2 h at 37°C with 5% CO2, in order 
to kill non-internalized bacteria. Subsequently, DCs were 
lysed in 100 µL PBS with 2% Triton X-100 (Sigma). The 
lysates, containing internalized bacteria, were plated 
on MRS plates and colony forming units (CFU) were 
counted. Experiments were repeated three times, each 
time on three different mice for BMDCs. For hDCs, were 
repeated also three times the experiment but on the same 
four different blood donors.
In competition experiments, the hDCs were pre-incu-
bated for 1 h with monoclonal anti-human CD205 Anti-
body [Purified anti-human CD205 (DEC-205) Antibody; 
Biolegend] at a final concentration of 2  µg/mL, prior to 
addition of the bacteria.
Plasmid delivery to DCs
BMDCs or hDCs were co-incubated with the different 
bacterial strains as described above. After incubation, the 
cells were washed three times with RPMI and grown for 
36  h in RPMI 1640 medium (PAA Laboratories GmbH) 
containing 1 mM sodium pyruvate, 50 mM thioglycerol, 
25 µg/mL penicillin streptomycin (Garamycin), 10% fetal 
calf serum (Gibco Life Technologies). Thereafter approxi-
mately 1 ×  106 harvested cells were washed three times 
with cold PBS and them resuspended in 300  µL PBS-B. 
GFP expression was analyzed by flow cytometry using a 
MACSQuant analyzer (Miltenyi Biotec GmbH), follow-
ing the manufacturer’s instructions. Experiments were 
repeated three times, each time on three different mice 
for BMDCs. For hDCs, were repeated also three times the 
experiment but on the same four different blood donors.
Experimental protocol for animal experiments
Groups of 6 C57BL/6 mice (Janvier) were fed by gavage 
during 4 days with 1 × 109 bacteria/day in 100 µL PBS. At 
day 4, the mice were euthanized by cervical elongation, the 
intestine and colon were withdrawn, opened longitudi-
nally, and cut into 5 mm pieces which were washed 4 times 
by incubation for 20  min at 37°C in 5  mL PBS contain-
ing 2  mM EDTA, with strong shaking (>250  rpm). After 
each incubation, the samples were centrifuged at 500×g 
for 5  min and the supernatant, containing enterocytes, 
was discarded. Then, the fragments were incubated three 
times for 45 min at 37°C with strong shaking (>250 rpm) 
in 100U/mL of collagenase D (Roche), 30  µg DNase 1 
(Sigma), 20% v/v fetal calf serum (Gibco Life Technologies) 
in PBS. The samples were centrifuged at 500×g for 5 min 
after each incubation and supernatants were collected, 
pooled and filtered with a 70 µm Falcon cell strainer (Fal-
con). The extracted cells were sorted with a Macs separa-
tor using mouse CD11c beads (Miltenyi Biotec) to collect 
DCs, according to the manufacturer’s instructions. Mark-
ing of the mouse DCs thus isolated was analyzed by flow 
cytometry using a MACSQuant analyzer (Miltenyi Biotec 
GmbH), following the manufacturer’s instructions.
Statistical tests
Statistical significance was tested using the Mann–Whitney 
test on Prism (GraphPad software). Results are presented 
as mean ± SEM. Statistical significance was considered for 
p < 0.05. * is p < 0.05, ** is p < 0.01 and *** is p < 0.001.
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